Close Menu
PharmaSignal
  • Home
  • Contact Us
  • About Us
  • FAQs
  • Legal Disclaimer
  • Privacy Policy
  • Editorials
  • Frequently Asked Questions
  • Homepage
  • Weekly Pharma BD Signals
Newsletter

Subscribe to Updates

Get the latest creative news from Pharmasignal.

Newsletter

Subscribe to our newsletter and stay updated.

LinkedIn

PharmaSignal

  • Home
  • Regulatory
  • Deals
  • Market Access
  • R&D
  • PharmaSignal Explainers
  • Weekly Digest
LinkedIn
PharmaSignal
  • Home
  • Regulatory
  • Deals
  • Market Access
  • R&D
  • PharmaSignal Explainers
  • Weekly Digest

PharmaSignal Explainers — How Pharma Deals Really Work

Why Peak-Sales Models Survive Long After Their Credibility Breaks

February 9, 2026
PharmaSignal Explainers

How Local Pricing Autonomy Gets Engineered Out at Deal Sign-Off

By sagarmahajan2886@gmail.comDecember 29, 20250
PharmaSignal Explainers

Why “Approved” Filings Unravel After Central Teams Disengage

By PharmaSignal News DeskDecember 18, 20250

Trending

M&A and Licensing

GSK acquires Nuvalent in $11B deal to enhance cancer pipeline

2 Mins Read
M&A and Licensing

J&J Acquires Firefly to Enhance Cancer Drug Portfolio

2 Mins Read
M&A and Licensing

Alnylam partners with Inceptive in AI drug discovery

3 Mins Read
M&A and Licensing

RallyBio Merges with Avenzo to Target Rare Diseases

2 Mins Read

Deals in focus

M&A and Licensing

Servier Ideaya Deal: $200M Upfront Payment

M&A and Licensing

Cormorant secures $150M for new SPAC merger in biotech

M&A and Licensing

Xoma acquires Generation Bio in strategic biotech move

M&A and Licensing

Arvinas and Pfizer Partner with Rigel for Veppanu

Pharma BD Signals — Strategic Signals Behind Deals

Weekly Pharma BD Signals

A 5-minute weekly brief for pharma BD and alliance leaders
covering deal structures, execution risks, access assumptions, and where value quietly leaks post-signing.

markets

Market Access

Trump Administration Unveils Medicare Drug Prices

November 28, 2025By PharmaSignal News Desk

Medicare Drug Prices for 15 drugs unveiled, saving $8.5 billion, a 36% reduction.

Market & Financials

Aktis Files for IPO Amid Biotech Sector Recovery

GSK acquires Nuvalent in $11B deal to enhance cancer pipeline

J&J Acquires Firefly to Enhance Cancer Drug Portfolio

Weekly digest

Deal of the Month

Deal of the Month: Deal Signals to note

A senior BD execution signal from this month’s most instructive pharma deal.
​

Type above and press Enter to search. Press Esc to cancel.